Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Urecholine, Duvoid, Myotonachol
Bethanechol is a cholinergic agonist that stimulates muscarinic receptors, primarily in the parasympathetic nervous system. It mimics the effects of acetylcholine, promoting smooth muscle contraction in the bladder and gastrointestinal tract. It is used to treat urinary retention, particularly postoperatively or postpartum, and sometimes for gastrointestinal hypomotility.
Used to treat urinary retention and gastrointestinal hypomotility.
Outcome:
Reduced effectiveness of bethanechol.
Mechanism:
Competitive antagonism at muscarinic receptors.
Outcome:
Additive cholinergic effects.
Mechanism:
Synergistic stimulation of muscarinic receptors.
Outcome:
Potential decrease in bethanechol absorption.
Mechanism:
Altered gastric pH.
Most likely new formulation: Extended-release oral formulation (Year: 2026, 30% confidence)
Based on current usage trends and clinical trial data, there is a low probability (<5%) of bethanechol being withdrawn from the market in the next 5 years.
Cholinergic Agonist, Muscarinic Agonist
Choline Ester